ATE432712T1 - Kombinationsvakzine enthaltend toxoid des dermonecrotischen toxins von bordetella bronchiseptica - Google Patents

Kombinationsvakzine enthaltend toxoid des dermonecrotischen toxins von bordetella bronchiseptica

Info

Publication number
ATE432712T1
ATE432712T1 AT02028045T AT02028045T ATE432712T1 AT E432712 T1 ATE432712 T1 AT E432712T1 AT 02028045 T AT02028045 T AT 02028045T AT 02028045 T AT02028045 T AT 02028045T AT E432712 T1 ATE432712 T1 AT E432712T1
Authority
AT
Austria
Prior art keywords
toxoid
dermonecrotic toxin
dermonecrotic
bordetella
gel
Prior art date
Application number
AT02028045T
Other languages
English (en)
Inventor
Toru Kawai
Kozo Takase
Toshihiro Ushijima
Hideo Fujikawa
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE432712T1 publication Critical patent/ATE432712T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02028045T 1994-06-10 1995-06-07 Kombinationsvakzine enthaltend toxoid des dermonecrotischen toxins von bordetella bronchiseptica ATE432712T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15283494 1994-06-10

Publications (1)

Publication Number Publication Date
ATE432712T1 true ATE432712T1 (de) 2009-06-15

Family

ID=15549157

Family Applications (2)

Application Number Title Priority Date Filing Date
AT95921113T ATE248603T1 (de) 1994-06-10 1995-06-07 Reinigungsverfahren für von bordetella produziertem nekrotoxin
AT02028045T ATE432712T1 (de) 1994-06-10 1995-06-07 Kombinationsvakzine enthaltend toxoid des dermonecrotischen toxins von bordetella bronchiseptica

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT95921113T ATE248603T1 (de) 1994-06-10 1995-06-07 Reinigungsverfahren für von bordetella produziertem nekrotoxin

Country Status (10)

Country Link
US (1) US6124432A (de)
EP (2) EP1297845B1 (de)
JP (2) JP3884066B2 (de)
CN (2) CN1279978C (de)
AT (2) ATE248603T1 (de)
CA (1) CA2192165A1 (de)
DE (2) DE69531690T2 (de)
DK (2) DK0773030T3 (de)
ES (2) ES2206507T3 (de)
WO (1) WO1995034322A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769539B2 (en) 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US7521059B2 (en) * 2004-06-14 2009-04-21 Fenwick Bradley W Kennel cough vaccine
CN103153337A (zh) 2010-09-28 2013-06-12 共立制药股份有限公司 黏膜佐剂组合物
IT201600076743A1 (it) * 2016-07-21 2018-01-21 St Superiore Di Sanita Nuovo uso del cnf1
CN107338208B (zh) * 2017-08-17 2020-07-28 天康生物股份有限公司 一种猪萎缩性鼻炎d型产毒多杀巴斯德氏菌疫苗株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
DE69131525T2 (de) * 1990-06-13 1999-11-25 Pfizer Inc., New York Pasteurella multocida toxoid enthaltende impfstoffe

Also Published As

Publication number Publication date
US6124432A (en) 2000-09-26
JP2006342175A (ja) 2006-12-21
DE69535964D1 (de) 2009-07-16
DE69531690T2 (de) 2004-07-08
CN1130225C (zh) 2003-12-10
ES2326793T3 (es) 2009-10-20
CN1279978C (zh) 2006-10-18
JP4340672B2 (ja) 2009-10-07
DK1297845T3 (da) 2009-07-13
EP0773030A1 (de) 1997-05-14
JP3884066B2 (ja) 2007-02-21
WO1995034322A1 (en) 1995-12-21
CN1154655A (zh) 1997-07-16
EP0773030B8 (de) 2004-01-14
CA2192165A1 (en) 1995-12-21
EP0773030B1 (de) 2003-09-03
ATE248603T1 (de) 2003-09-15
ES2206507T3 (es) 2004-05-16
DE69531690D1 (de) 2003-10-09
EP1297845A2 (de) 2003-04-02
EP1297845A3 (de) 2003-04-16
DK0773030T3 (da) 2003-12-22
EP1297845B1 (de) 2009-06-03
EP0773030A4 (de) 1997-12-10
CN1494922A (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
Helting et al. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.
DE3478789D1 (en) Vaccines for gram-negative bacteria and method for the preparation thereof
KR860004923A (ko) 폴리삭카라이드-단백질 결합체, 이의 제조방법 및 이를 함유하는 조성물
NO1997010I1 (no) Bordetella pertussis P69 antigen
DE69535964D1 (de) Kombinationsvakzine enthaltend Toxoid des dermonecrotischen Toxins von Bordetella bronchiseptica
ATE220688T1 (de) Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen
EP0385118A3 (de) Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen
FI101380B (fi) Menetelmä 69 000 daltonin antigeeniproteiinin puhdistamiseksi Bordetel la pertussis -bakteerista
ATE2090T1 (de) Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel.
DK0680765T3 (da) Vaccine til ikke-typebestemmelig Haemophilus influenzae-stamme
GR880300042T1 (en) Material for affinity chromatography and its use in the separation and purification of protein antigens from bacteria of the genus bordetella
PT95789A (pt) Metodo para isolamento e purificacao de factores antigenicos da bordetella pertussis
ES517473A0 (es) Procedimiento para la obtencion de esencias aromatizantes enriquezidas.
EP0090660A3 (de) Neisseria Gonorrhöe Vakzin
FR2422699A1 (fr) Procede de preparation d'un materiau solide poreux revetu de cellulose ou de cellulose modifiee
US4845036A (en) Process for isolation of the B oligomer of pertussis toxin
GB2007244A (en) Purifying Polyribosyl Ribitol Phosphate (PRP) and Vaccines containing Immunologically Active PRP
GR3006766T3 (de)
Callahan 3rd et al. Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives
SE8604587D0 (sv) Lekemedelssats for sarlekningsstimulering samt sett att anvenda och tillverka satsen
PL271055A1 (en) Method for lowering nitrogen oxide and other pollutant content in flue gases
DK163582A (da) Fremgangsmaade til rensning af et fysiologisk aktivt stof med antitumorvirkning
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.
SE8303096L (sv) Lagtoxiskt kikhostevaccin
FR2104732A1 (en) Asparaginase purification using asparagine in - hibitors coupled to carbohydrate matrix

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties